Current issue
Archive
Videos
Articles in press
About the journal
Supplements
Editorial board
Reviewers
Abstracting and indexing
Subscription
Contact
Instructions for authors
Publication charge
Ethical standards and procedures
Editorial System
Submit your Manuscript
|
3/2021
vol. 123 abstract:
Review paper
Mycotic corneal ulcers caused by Fusarium spp.- available therapeutic options
Ewelina Trojacka
1
,
Justyna Izdebska
1, 2
,
Marta Wroblewska
3, 4
,
Beata Sulik-Tyszka
3, 4
,
Karolina Ciepiaszuk
1, 2
,
Jacek P. Szaflik
1
KLINIKA OCZNA 2021, 123, 3: 108–113
Online publish date: 2021/10/13
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Fungal corneal ulcers caused by Fusarium spp. are known as sight threatening infection with bad course.
Fungus properties, diagnostic difficulties and limited therapeutic ways result in poor outcomes. Three of antimycotic drugs are effective against Fusarium spp.: natamycin, amphotericin B and voriconazole. Natamycin is the only drug approved by FDA (Food and Drug Administration) for treatment of corneal ulcers caused by Fusarium spp. Fungistatic work and limited ocular penetration of antimycotic drugs lead to therapeutic keratoplasty in cases with extremely bad course. Patient with recurrent infections and very advanced inflammation, require enucleation. keywords:
corneal ulcer, Fusarium spp, natamycin, voriconazole, therapeutic penetrating keratoplasty |
|